Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Exploring staff attitudes to routine HIV testing in non-traditional settings: a qualitative study in four healthcare facilities.

Thornton AC, Rayment M, Elam G, Atkins M, Jones R, Nardone A, Roberts P, Tenant-Flowers M, Anderson J, Sullivan AK; HINTS Study Group.

Sex Transm Infect. 2012 Dec;88(8):601-6. doi: 10.1136/sextrans-2012-050584. Epub 2012 Jul 6.

PMID:
22773329
2.

HIV testing in non-traditional settings--the HINTS study: a multi-centre observational study of feasibility and acceptability.

Rayment M, Thornton A, Mandalia S, Elam G, Atkins M, Jones R, Nardone A, Roberts P, Tenant-Flowers M, Anderson J, Sullivan AK; HINTS Study Group.

PLoS One. 2012;7(6):e39530. doi: 10.1371/journal.pone.0039530. Epub 2012 Jun 22.

3.

Projected life expectancy of people with HIV according to timing of diagnosis.

Nakagawa F, Lodwick RK, Smith CJ, Smith R, Cambiano V, Lundgren JD, Delpech V, Phillips AN.

AIDS. 2012 Jan 28;26(3):335-43. doi: 10.1097/QAD.0b013e32834dcec9.

PMID:
22089374
4.

The economic burden of late entry into medical care for patients with HIV infection.

Fleishman JA, Yehia BR, Moore RD, Gebo KA; HIV Research Network.

Med Care. 2010 Dec;48(12):1071-9. doi: 10.1097/MLR.0b013e3181f81c4a.

5.

Routine HIV screening in France: clinical impact and cost-effectiveness.

Yazdanpanah Y, Sloan CE, Charlois-Ou C, Le Vu S, Semaille C, Costagliola D, Pillonel J, Poullié AI, Scemama O, Deuffic-Burban S, Losina E, Walensky RP, Freedberg KA, Paltiel AD.

PLoS One. 2010 Oct 1;5(10):e13132. doi: 10.1371/journal.pone.0013132.

6.

Late diagnosis in the HAART era: proposed common definitions and associations with mortality.

UK Collaborative HIV Cohort (UK CHIC) Steering Committee, Sabin CA, Schwenk A, Johnson MA, Gazzard B, Fisher M, Walsh J, Orkin C, Hill T, Gilson R, Porter K, Easterbrook P, Delpech V, Bansi L, Leen C, Gompels M, Anderson J, Phillips AN.

AIDS. 2010 Mar 13;24(5):723-7. doi: 10.1097/QAD.0b013e328333fa0f.

PMID:
20057312
7.

[Late AIDS diagnosis in patients hospitalized in Clinic of Infectious Diseases and Hepatology PAM in years 2003-2007].

Bander D, Leszczyszyn-Pynka M, Boroń-Kaczmarska A.

Przegl Epidemiol. 2009;63(1):61-6. Polish.

PMID:
19522228
8.

Initiation of HAART at higher CD4 cell counts is associated with a lower frequency of antiretroviral drug resistance mutations at virologic failure.

Uy J, Armon C, Buchacz K, Wood K, Brooks JT; HOPS Investigators.

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):450-3. doi: 10.1097/QAI.0b013e3181acb630.

PMID:
19474757
9.

Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: a cohort of high-risk men who have sex with men.

Fox J, White PJ, Macdonald N, Weber J, McClure M, Fidler S, Ward H.

HIV Med. 2009 Aug;10(7):432-8. doi: 10.1111/j.1468-1293.2009.00708.x. Epub 2009 May 5.

10.

Indicator disease-guided testing for HIV--the next step for Europe?

Gazzard B, Clumeck N, d'Arminio Monforte A, Lundgren JD.

HIV Med. 2008 Jul;9 Suppl 2:34-40. doi: 10.1111/j.1468-1293.2008.00592.x. Review.

11.

Diagnosed and undiagnosed HIV-infected populations in Europe.

Hamers FF, Phillips AN.

HIV Med. 2008 Jul;9 Suppl 2:6-12. doi: 10.1111/j.1468-1293.2008.00584.x. Review.

12.

Late diagnosis of HIV infection: major consequences and missed opportunities.

Fisher M.

Curr Opin Infect Dis. 2008 Feb;21(1):1-3. doi: 10.1097/QCO.0b013e3282f2d8fb. Review. No abstract available.

PMID:
18192778
13.

Infections prevented by increasing HIV serostatus awareness in the United States, 2001 to 2004.

Pinkerton SD, Holtgrave DR, Galletly CL.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):354-7. doi: 10.1097/QAI.0b013e318160d57e.

14.

Frequency, determinants and consequences of delayed access to care for HIV infection in France.

Lanoy E, Mary-Krause M, Tattevin P, Perbost I, Poizot-Martin I, Dupont C, Costagliola D; ANRS C004 French Hospital Database on HIV Clinical Epidemiological Group.

Antivir Ther. 2007;12(1):89-96.

PMID:
17503752
15.
16.

Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe.

Bannister WP, Kirk O, Gatell JM, Knysz B, Viard JP, Mens H, Monforte AD, Phillips AN, Mocroft A, Lundgren JD; EuroSIDA Study Group.

J Acquir Immune Defic Syndr. 2006 Jun;42(2):229-37.

PMID:
16760800
17.

No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993-2002).

Chadborn TR, Baster K, Delpech VC, Sabin CA, Sinka K, Rice BD, Evans BG.

AIDS. 2005 Mar 25;19(5):513-20.

PMID:
15764857
18.

Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

Paltiel AD, Weinstein MC, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, Freedberg KA, Walensky RP.

N Engl J Med. 2005 Feb 10;352(6):586-95.

19.

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK.

N Engl J Med. 2005 Feb 10;352(6):570-85.

20.

Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults.

Schackman BR, Freedberg KA, Weinstein MC, Sax PE, Losina E, Zhang H, Goldie SJ.

Arch Intern Med. 2002 Nov 25;162(21):2478-86.

PMID:
12437408
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk